Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6717-6723

  Yamada, S Diane ^a   Hickson, Jonathan A ^a   Hrobowski, Yancey ^a   Vander Griend, Donald J ^a   Benson, David ^a   Montag, Anthony ^a   Karrison, Theodore ^a   Huo, Dezheng ^a   Rutgers, Joanne ^b   Adams, Sarah ^a   Rinker Schaeffer, Carrie W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INJECTION; LIFESPAN; METASTASIS; MULTIGENE FAMILY; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DIVISION; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0037112512     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics, 2002. CA Cancer J. Clin., 52: 23-47, 2002
2. Leone, A., Flatow, U., VanHoutte, K., and Steeg, P. S. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene, 8: 2325-2333, 1993
3. Seraj, M. J., Samant, R. S., Verderame, M. F., and Welch, D. R. Functional evidence for a novel human breast carcinoma metastasis suppressor. BRMS1, encoded at chromosome 11q13. Cancer Res., 60: 2764-2769, 2000
4. Lee, J. H., and Welch, D. R. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene KiSS-1. Cancer Res., 57: 2384-2387, 1997
5. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Wash. DC), 268: 884-886, 1995
6. Takaoka, A., Hinoda, Y., Sato, S., Itoh, F., Adachi, M., and Imai, K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene, 16: 1443-1453, 1998
7. Leone, A., Flatow, U., King, C. R., Sandeen, M. A., Margulies, I. M., Liotta, L. A., and Steeg, P. S. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm-23 transfected melanoma cells. Cell, 65: 25-35, 1991
8. Kantor, J. D., McCormick, B., Steeg, P. S., and Zetter, B. R. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res., 53: 1971-1973, 1993
9. Yoshida, B. A., Sokoloff, M., Welch, D. R., Rinker-Schaeffer, C. W. Metastasis-suppressor genes: A review and perspective on an emerging field. J. Natl. Cancer Inst., 92: 1717-1730. 2000
10. Chekmareva, M. A., Kadkhodaian, M. M., Hollowell, C. M., Kim, H., Yoshida, B. A., Luu, H. H., Stadler, W. M., and Rinker Schaeffer, C. W. Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases. Cancer Res., 58: 4963-4969, 1998
11. Goldberg, S. F., Harms, J. F., Quon, K., and Welch, D. R. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clin. Exp Metastasis, 17: 601-607, 1999
12. Schindl, M., Birner, P., Breitenecker, G., and Oberhuber, G. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer. Gynecol. Oncol., 83: 244-248, 2001
13. Liu, F. S., Dong, J. T., Chen, J. T., Hsieh, Y. T., Ho, E. S., and Hung, M. J. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol. Oncol., 78: 10-15, 2000
14. Scambia, G., Ferrandina, G., Marone, M., Benedetti Panici, P., Giannitelli, C., Piantelli, M., Leone, A., and Mancuso, S. nm23 in ovarian cancer: Correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J. Clin. Oncol., 14: 334-342, 1996
15. Tas, F., Tuzlali, S., Aydiner, A., Saip, P., Salihoglu, Y., Iplikci, A., and Topuz, E. Prognostic role of nm23 gene expression in patients with ovarian cancer. Am. J. Clin. Oncol., 25: 164-167, 2002
16. Schneider, J., Pollan, M., Jimenez, E., Marenbach, N. K., Martinez, N., Volm, M., Marx, D., and Meden, H. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma. Br. J. Cancer, 82: 1662-1670. 2000
17. Cuenda, A. Mitogen-activated protein kinase kinase 4 (MKK4) Int. J. Biochem. Cell Biol., 32: 581-587, 2000
18. Yoshida, B. A., Dubauskas, Z., Chekmareva, M. A., Christiano, T. R., Stadler W. M., and Rinker-Schaeffer, C. W. Mitogen-activated protein kinase kinase 4/stress activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17. Cancer Res., 59: 5483-5487, 1999
19. Kim, H. L., Vander Griend, D. J., Yang, X., Benson, D. A., Dubauskas, Z., Yoshida, B. A., Chekmareva, M. A., Ichikawa, Y., Sokoloff, M. H., Zhan, P., Karrison, T., Lin, A., Stadler, W. M., Ichikawa, T., Rubin, M. A., and Rinker-Schaeffer, C. W. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Res., 61: 2833-2837, 2001
20. Yoneda, J., Kuniyasu, H., Crispens, M. A., Price, J. E., Bucana, C. D., and Fidler, I. J. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice, J. Natl. Cancer Inst., 90: 447-454, 1998
21. Kajiyama, H., Kikkawa, F., Suzuki, T., Shibata, K., Ino, K., and Mizutani, S. Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res., 62: 2753-2757, 2002
22. Moses, L. E., Emerson, J. D., and Hosseini, H. Analyzing data from ordered categories. N. Engl. J. Med., 311: 442-448, 1984
23. Crowder, M. J., and Hand, D. J. In: Analysis of Repeated Measures, pp. 25-59. London: Chapman and Hall, 1990
24. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-481, 1958
25. Ganiatsas, S., Kwee, L., Fujiwara, Y., Perkins, A., Ikeda, T., Labow, M. A., and Zon, L. I. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc. Natl. Acad. Sci. USA, 95: 6881-6886, 1998
26. Thangaraju, M., Kaufmann, S. H., and Couch, F. J. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J. Biol. Chem., 275: 33487-33496, 2000
27. Wang, T., Wang, H., Ichijo, H., Giannakakou, P., Foster, J. S., Fojo, T., and Wimalasena, J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress activated protein kinase through both ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem., 273: 4928-4936, 1998
28. Wang, T., Popp, D. M., Wang, H., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H., and Wimalasena, J. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and-independent pathways in ovarian cancer cells. J. Biol. Chem., 274: 8202-8216, 1999
29. Lee, L., Li, G., Templeton, D. J., and Ting, J. P. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J. Biol. Chem., 273: 28253-28260, 1998